Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Extended Follow-up of Patients With Macular Edema Due to Retinal Vein Occlusion

ClinicalTrials.gov ID: NCT01198327

Public ClinicalTrials.gov record NCT01198327. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 5:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Extended Follow-up of Patients With Macular Edema Due to bRanch rETinal Vein Occlusion (BRVO) or centrAl Retinal veIn occlusioN (CRVO) Previously Treated With Intravitreal Ranibizumab

Study identification

NCT ID
NCT01198327
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Peter A Campochiaro, MD
Other
Enrollment
66 participants

Conditions and interventions

Interventions

  • ranibizumab Drug
  • Peripheral Laser Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2010
Primary completion
Nov 30, 2012
Completion
Nov 30, 2012
Last update posted
Jan 12, 2014

2010 – 2012

United States locations

U.S. sites
6
U.S. states
5
U.S. cities
6
Facility City State ZIP Site status
Retina-Vitreous Associates Medical Group Beverly Hills California 90211
Retinal Consultants Medical Group Sacremento California 95819
Southeast Retina Augusta Georgia 30909
Ophthalmic consultants of Boston Boston Massachusetts 02114-2587
Retina Associates of New Jersey Teaneck New Jersey 07666
Retina Consultants of Houston Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01198327, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 12, 2014 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01198327 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →